New device may make ECMO removal safer for heart and lung patients
NCT ID NCT07019662
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study looks at a new way to close the artery after removing the ECMO life-support machine. About 102 adults on ECMO for severe heart and lung failure will be randomly assigned to either a stitch-based closure device or standard care (manual pressure or surgery). The goal is to see if the device is as safe and effective at preventing complications like bleeding or blood clots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VA-ECMO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Universitäres Herz- und Gefäßzentrum Frankfurt ZIM - Med. Clinic 3 - Cardiology and Angiology
RECRUITINGFrankfurt, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie
RECRUITINGMainz, Germany
Conditions
Explore the condition pages connected to this study.